Literature DB >> 26318175

In vitro interaction between coxsackievirus B3 VP1 protein and human pleckstrin homology domain retinal protein (PHR1).

Ying Zhou1, Zhiqin Zhang1, Hongluan Wang2, Yanhua Xia1, Xiuzhen Li1, Yan Yan1, Weiwen Zou1, Lingbing Zeng3, Xiaotian Huang4.   

Abstract

Coxsackievirus B3 (CVB3) infection causes central nervous system diseases including aseptic meningitis and encephalitis. To understand the mechanism of this virus, a yeast two-hybrid system was used to screen cellular proteins from a human heart cDNA library. The results revealed that the human Pleckstrin Homology Domain Retinal protein (PHR1), a PH domain-containing protein with low expression in the heart and high expression in the brain, interacts with CVB3 VP1, a major structural protein of CVB3. Yeast mating assays and in vitro coimmunoprecipitation verified the interaction between CVB3 VP1 and PHR1. An α-galactosidase assay indicated that of α-galactosidase activity was higher in positive clones than in controls suggesting a strong interaction. Furthermore, assay of deletion mutants defined the minimal region of PHR1 required for its interaction with VP1 as amino acids 95-172 and two regions of VP1 required for its interaction with PHR1 as amino acids 729-767 and 811-859. The results revealed multiple binding sites between PHR1 and CVB3 VP1 and suggested that the strong interaction between these two proteins might play an important role in central nervous system disease in the human brain.

Entities:  

Keywords:  Coxsackievirus B3 VP1; Interaction; Pleckstrin homology domain retinal protein (PHR1)

Mesh:

Substances:

Year:  2015        PMID: 26318175     DOI: 10.1007/s11262-015-1241-6

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  23 in total

1.  PHR1 encodes an abundant, pleckstrin homology domain-containing integral membrane protein in the photoreceptor outer segments.

Authors:  S Xu; R Ladak; D A Swanson; A Soltyk; H Sun; L Ploder; D Vidgen; A M Duncan; E Garami; D Valle; R R McInnes
Journal:  J Biol Chem       Date:  1999-12-10       Impact factor: 5.157

2.  Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment.

Authors:  Michaela Schmidtke; Elke Hammerschmidt; Susanne Schüler; Roland Zell; Eckhard Birch-Hirschfeld; Vadim A Makarov; Olga B Riabova; Peter Wutzler
Journal:  J Antimicrob Chemother       Date:  2005-09-08       Impact factor: 5.790

3.  The requirement for Phr1 in CNS axon tract formation reveals the corticostriatal boundary as a choice point for cortical axons.

Authors:  A Joseph Bloom; Bradley R Miller; Joshua R Sanes; Aaron DiAntonio
Journal:  Genes Dev       Date:  2007-09-27       Impact factor: 11.361

4.  Enhancement of coxsackievirus B3 infection by antibody to a different coxsackievirus strain.

Authors:  Jaskamal Girn; Mojgan Kavoosi; Janet Chantler
Journal:  J Gen Virol       Date:  2002-02       Impact factor: 3.891

5.  Genome of coxsackievirus B3.

Authors:  A M Lindberg; P O Stålhandske; U Pettersson
Journal:  Virology       Date:  1987-01       Impact factor: 3.616

6.  Viral protein VP4 is a target of human antibodies enhancing coxsackievirus B4- and B3-induced synthesis of alpha interferon.

Authors:  Wassim Chehadeh; Pierre-Emmanuel Lobert; Pierre Sauter; Anne Goffard; Bernadette Lucas; Jacques Weill; Marie-Christine Vantyghem; Gunnar Alm; Pascal Pigny; Didier Hober
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

7.  Pleckstrin domain homology.

Authors:  R J Haslam; H B Koide; B A Hemmings
Journal:  Nature       Date:  1993-05-27       Impact factor: 49.962

8.  PHR1, a PH domain-containing protein expressed in primary sensory neurons.

Authors:  Shunbin Xu; Yanshu Wang; Haiqing Zhao; Lilei Zhang; Weihong Xiong; King-Wai Yau; Hakim Hiel; Elisabeth Glowatzki; David K Ryugo; David Valle
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

9.  Nucleotide sequence of an attenuated mutant of coxsackievirus B3 compared with the cardiovirulent wildtype: assessment of candidate mutations by analysis of a revertant to cardiovirulence.

Authors:  C L Cameron-Wilson; Y A Pandolfino; H Y Zhang; B Pozzeto; L C Archard
Journal:  Clin Diagn Virol       Date:  1998-04

10.  Coxsackievirus-induced acute neonatal central nervous system disease model.

Authors:  Lulu Wang; Changyuan Dong; Dong-E Chen; Zhen Song
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15
View more
  1 in total

1.  Motor neuron translatome reveals deregulation of SYNGR4 and PLEKHB1 in mutant TDP-43 amyotrophic lateral sclerosis models.

Authors:  Rita F Marques; Jan B Engler; Katrin Küchler; Ross A Jones; Thomas Lingner; Gabriela Salinas; Thomas H Gillingwater; Manuel A Friese; Kent E Duncan
Journal:  Hum Mol Genet       Date:  2020-09-29       Impact factor: 6.150

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.